(Q45055092)

English

Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms

scientific article published in August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 December 2017

Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms (English)

1 reference

Europe PubMed Central

9 December 2017

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

positron emission tomography

1 reference

based on heuristic

inferred from title

1

object named as

Vesna Sossi

1 reference

Europe PubMed Central

9 December 2017

author name string

Raúl de la Fuente-Fernández

2

1 reference

Europe PubMed Central

9 December 2017

James E Holden

3

1 reference

Europe PubMed Central

9 December 2017

Michael Schulzer

4

1 reference

Europe PubMed Central

9 December 2017

Thomas J Ruth

5

1 reference

Europe PubMed Central

9 December 2017

Jon Stoessl

6

1 reference

Europe PubMed Central

9 December 2017

publication date

1 August 2004

1 reference

Europe PubMed Central

9 December 2017

Journal of Cerebral Blood Flow & Metabolism

1 reference

Europe PubMed Central

9 December 2017

24

1 reference

Europe PubMed Central

9 December 2017

8

1 reference

Europe PubMed Central

9 December 2017

869-876

1 reference

Europe PubMed Central

9 December 2017

describes a project that uses

positron emission tomography

1 reference

based on heuristic

inferred from title

https://scigraph.springernature.com/pub.10.1097/01.wcb.0000126563.85360.75

0 references

6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

New rapid analysis method demonstrates differences in 6-[18F]fluoro-l-dopa plasma input curves with and without carbidopa and in hemi-MPTP lesioned monkeys

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins.

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: Door-to-door community studies

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

A reversible tracer analysis approach to the study of effective dopamine turnover

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Physical performance of a positron tomograph for brain imaging with retractable septa

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000126563.85360.75

21 January 2018

Identifiers

10.1097/01.WCB.0000126563.85360.75

1 reference

Europe PubMed Central

9 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45055092&oldid=2074854594"